News

According to the company, this new system requires no coding, displays results in seven seconds, requires a tiny 0.3 micro liter sample size, and was developed to use

The acquisition gains PPD immediate entry into Romania, Bulgaria, Serbia and Croatia with established infrastructure and expertise, and also bolsters PPD’s existing staff and operations in Poland, Russia

From 1999 through 2009, Dr Brzeczko was vice president of global pharma new product development and pharma technologies for International Specialty Products, a contract services group specializing in

The goal of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics (induction of hematopoiesis) of HYC750, a patent-protected formulation of hyaluronan. Orcrist utilized the regulatory

Pro-forma Fourth quarter 2008 Net sales increased by six percent to SEK143.2 million (134.5). At comparable exchange rates sales decreased by 7 percent. The operating profit amounted to

Reporting to Eric Jacobson, senior vice president and chief medical officer, Dr Vukovic will be the Synta medical leader for the company’s most advanced oncology product candidate, elesclomol,

This financing provides the company with sufficient capital to develop iCo-007 through to the completion of the Phase I clinical trial. iCo-007 is targeting the treatment of diabetic

Under the agreement, RTI will process cervical and lumbar spinal grafts from designs developed by Aesculap Implant Systems. Brian Hutchison, chairman and CEO of RTI, said: “We are

US president Barack Obama recently selected Mr Roosevelt as part of his transition team to co-chair a review of the social security administration. Mr Roosevelt serves as chairman